Vaccine Development And Medical Diagnosis

The rapid creation of COVID-19 vaccines proved AI’s value in biotechnology. Machine learning tools helped compress a 15-year development cycle into about 12 months by interpreting genomes and optimising trial data. Now, AI systems are set to make vaccine design nearly instantaneous.

According to Dr. Timothy Endy of CEPI, with a pandemic threat, researchers could design a new vaccine “within a matter of days.”

CEPI’s mission is to shorten vaccine rollout to 100 days, and AI-driven antigen design shows it’s within reach. By predicting viral mutations and crafting stable immunogens ahead of time, AI gives scientists a head start in the race against Disease X. The next outbreak might see effective vaccines formulated in days, not years, fundamentally transforming global health preparedness.

Artificial intelligence tools for medical imaging and decision support are becoming fixtures in hospitals worldwide. For example, in settings with few radiologists, Mumbai-based Qure.ai’s algorithms read X-rays, CT scans, and ultrasounds to catch diseases like TB or strokes. Qure’s software is now deployed in over 100 countries at thousands of clinics and has earned regulatory clearances for multiple critical conditions.

Similarly, California-based Viz.ai provides AI-driven stroke detection and care coordination, which has been installed in over 1,500 hospitals as of early 2024 and is growing. These systems flag urgent cases (like brain scans showing large-vessel blockages) and alert specialists within minutes, saving precious time in emergencies. Beyond imaging, AI is showing promise as a “clinical copilot” in primary care.

In a recent pilot in Kenya, clinicians used an AI assistant (co-developed by OpenAI and local provider Penda Health) during patient visits. The AI would analyse symptoms and the clinician’s notes in real-time, then double-check for errors or missed steps.

The outcome was a 16% reduction in diagnostic mistakes and a 13% drop in treatment errors. In thousands of patient visits, the AI quietly caught issues like a missed anaemia diagnosis or incorrect medication, prompting the doctor to correct course.

Importantly, doctors remained in control, and the AI served as a second set of eyes. With healthcare workforces stretched thin, such AI copilots could improve care quality, particularly in under-resourced regions. Global health experts predict that as validation studies continue, we’ll see wider adoption of medical AI tools, leading to earlier diagnoses, more consistent care, and lives saved.

Human–Machine Relationships

AI chatbots are becoming companions, blurring the line between tools and trusted friends. Platforms like Character.AI boast over 20 million monthly users, many of them young and female. These AI “friends” engage in conversations ranging from casual banter to pseudo-therapeutic sessions.

“For many people, it’s a fun diversion they get a lot out of,” notes Kate Devlin, a researcher of AI intimacy. She sees potential benefits in AI companionship, as long as users remember the AI isn’t truly sentient. However, there are concerns that vulnerable groups (e.g., children or those with mental health issues) might overshare with bots not designed to provide real counselling. As usage grows, society is adapting to these digital confidants.

Regulators and developers are debating safeguards, but overall, people seem resilient in navigating these relationships. As Devlin puts it, “We’re very good at being human,” and humans are learning where AI fits into our emotional lives.

Education

While schools grapple with students using AI tools like ChatGPT, educators are beginning to adopt AI for teaching as well. In the United States, major teacher unions partnered with tech companies on a five-year programme to train 400,000 K–12 teachers in AI use.

The initiative, backed by OpenAI, Microsoft, and others, aims to empower one in ten American teachers to integrate AI into lesson planning and personalised tutoring. Internationally, governments are also exploring AI’s role in education.

In India, OpenAI has agreed to provide ChatGPT access to hundreds of thousands of teachers and students, distributing 500,000 free licenses to public schools. Rose Luckin, a UCL professor specialising in AI education, notes that students’ rampant use of generative AI has disrupted traditional schooling but also opened opportunities.

She advocates teaching alongside AI and stresses the need for clear policies to protect privacy and academic integrity. The fundamental question, she says, is figuring out “what relationship do we want between human and artificial intelligence” in the classroom.

If done thoughtfully, artificial intelligence could augment teachers by automating administrative tasks and providing adaptive learning support, allowing teachers to focus on critical thinking and mentorship. The coming years will test how well education systems can harness AI’s benefits while mitigating its risks.

Automating Factories

Robots have long handled the heavy lifting in manufacturing, but now AI is giving them brains to match their brawn. A case in point is Chinese electronics giant Xiaomi recently unveiling a “dark factory” in Beijing that operates with almost no human labour.

This 81,000 m² smart facility uses AI-driven robotics and quality control systems to assemble up to 10 million smartphones per year, which is roughly one phone every few seconds. It runs 24/7 in the dark (since machines don’t need lights or coffee breaks) with only a handful of technicians monitoring the AI system.

Xiaomi’s custom AI manufacturing platform can even detect and fix problems on the line autonomously, optimising production without human intervention. Meanwhile, in Germany, Siemens is developing AI “industrial copilots” to assist factory engineers.

These AIs enable workers to control and programme industrial machines through natural language – telling a robot arm what task to do as simply as one might instruct a colleague. The copilot can also troubleshoot equipment by parsing error codes and suggesting fixes from maintenance manuals.

Siemens reports that early deployments of AI assistants have boosted efficiency by up to 30% in some processes (by reducing downtime and speeding up adjustments). “Much of AI’s future impact hinges on transforming the industrial world,” observes Siemens CTO Peter Koerte. Smarter automation could help factories cope with skilled labour shortages and increase productivity.

Dark factories and AI copilots might sound like sci-fi today, but they foreshadow a manufacturing sector where humans focus on design and oversight while AI-driven machines handle the repetitive assembly and diagnostics. It’s a shift that could reshape the economics of production across the globe.

Autonomous Military Drones

Warfare is entering the age of AI autonomy, as dramatically illustrated by Ukraine’s “Operation Spiderweb” in June 2025. In that covert strike, Ukrainian agents launched 117 drones from inside Russia, targeting strategic bomber bases spread across thousands of kilometres. When some drones lost contact due to Russian jamming, on-board AI reportedly took over navigation and guided them to their targets.

The result: a swarm of explosive-laden drones descended on multiple airfields, destroying 12 Russian long-range bombers on the ground and damaging many more. Mykhailo Fedorov, Ukraine’s Minister of Digital Transformation, called it the most “vivid” example of AI on the battlefield to date.

Militaries worldwide are taking note. While current drones still often have a human operator in the loop for strike decisions, the trend is toward greater autonomy for survival, as drones can jam or evade defences and complete missions even if cut off from controllers.

This raises ethical and strategic dilemmas. For example, will AI-powered drones make preemptive choices? How can we prevent unintended escalation if machines make mistakes? International discussions about “killer robots” and AI arms control are intensifying.

Nonetheless, the Spiderweb operation demonstrated a key future capability with relatively cheap AI-guided drones that could cripple billions in enemy hardware, levelling the playing field for smaller forces. As artificial intelligence continues to advance, it’s clear that aerial autonomy will play a growing role in conflicts. For better or worse, the next war might be fought as much by algorithms as by soldiers.

The post Check out the five AI applications shaping our future appeared first on International Finance.

While releasing the statement of the first-quarter results, they also focused on the fact that the output capacity for the vaccine would reach around 3 billion doses by the end of 2021, and they expect to produce another 3 billion doses by the end of 2022.

Last week, Pfizer also announced that both the pharma are targeting to produce as many as 4 billion doses by next year which will primarily cater to low and middle-income countries. Going to the delivery contracts, the company said that they are expecting a revenue of 12.4 billion Euros from the vaccines this year, which will include sales, milestone payments from partners, and a share of gross profits in the partners’ territories. Previously, it was forecast by the company that they were expecting revenue of 9.8 billion euros.

More than 450 million doses of the two-shot vaccine known as Comirnaty were administered globally as of May 6, 2021. Compared to that, AstraZeneca has pledged to deliver up to 3 billion doses this year, and according to their announcement, the pharma has supplied more than 300 million doses as of now, which includes production from their partners like Serum Institute of India.

Both BioNTech and Pfizer have not faced production setbacks which were witnessed by AstraZeneca, Johnson & Johnson. Earlier on Monday, BioNTech unveiled its plans to set up a new factory in Singapore where they are expected to produce several hundred million doses of mRNA vaccines every year from 2023.

The post BioNTech to deliver 1.2 bn doses of Covid-19 vaccines this year appeared first on International Finance.

“Vaccination is important to break the chain of Covid-19 transmission and give protection to us and safety to every Indonesian and help accelerate economic recovery,” Jokowi said after getting jabbed. Indonesia authorised the CoronaVac vaccine from China’s Sinovac Biotech, earlier this week.

Minister of Health Budi Gunadi Sadikin revealed that nearly 1.5 million medical workers would be inoculated by February. He said that Indonesia needs to vaccinate 181.5 million people, or nearly 67 percent of its population to reach herd immunity. This means the two-shot vaccine would require almost 427 million doses, including the estimate that 15 percent may be wasted.

Coordinating Economic Minister Airlangga Hartanto has said that Indonesia’s economic situation is expected to improve soon, as the government is preparing a number of recovery plans.

During a virtual discussion the minister said that he expects Indonesia’s economy to pick up. He said, “The signs are already here. The Covid-19 vaccine’s arrival will increase the public’s confidence and sense of security, which should lead them to restarting their activities. The economy is closely related to people’s mobility.”

The post Covid-19 vaccine to support Indonesia’s economic recovery: President appeared first on International Finance.